Kuros Biosciences Ltd (CSBTF)
7.10
-1.95
(-21.55%)
USD |
OTCM |
Apr 30, 16:00
Kuros Biosciences Max Drawdown (5Y): 95.00% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
March 31, 2024 | 95.00% |
February 29, 2024 | 95.00% |
January 31, 2024 | 95.00% |
December 31, 2023 | 95.00% |
November 30, 2023 | 95.00% |
October 31, 2023 | 95.00% |
September 30, 2023 | 95.00% |
August 31, 2023 | 95.00% |
July 31, 2023 | 95.00% |
June 30, 2023 | 95.00% |
May 31, 2023 | 95.00% |
April 30, 2023 | 95.00% |
March 31, 2023 | 95.00% |
February 28, 2023 | 95.00% |
January 31, 2023 | 95.00% |
December 31, 2022 | 95.00% |
November 30, 2022 | 95.00% |
October 31, 2022 | 95.00% |
September 30, 2022 | 95.00% |
August 31, 2022 | 95.00% |
July 31, 2022 | 95.00% |
June 30, 2022 | 95.00% |
May 31, 2022 | 95.00% |
April 30, 2022 | 95.00% |
March 31, 2022 | 95.00% |
Date | Value |
---|---|
February 28, 2022 | 95.00% |
January 31, 2022 | 95.00% |
December 31, 2021 | 95.00% |
November 30, 2021 | 95.00% |
October 31, 2021 | 95.00% |
September 30, 2021 | 95.00% |
August 31, 2021 | 95.00% |
July 31, 2021 | 95.00% |
June 30, 2021 | 95.00% |
May 31, 2021 | 95.00% |
April 30, 2021 | 95.00% |
March 31, 2021 | 95.00% |
February 28, 2021 | 95.00% |
January 31, 2021 | 95.00% |
December 31, 2020 | 95.00% |
November 30, 2020 | 95.00% |
October 31, 2020 | 95.00% |
September 30, 2020 | 95.00% |
August 31, 2020 | 95.00% |
July 31, 2020 | 95.00% |
June 30, 2020 | 95.00% |
May 31, 2020 | 95.00% |
April 30, 2020 | 95.00% |
March 31, 2020 | 95.00% |
February 29, 2020 | 95.00% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
72.29%
Minimum
May 2019
95.00%
Maximum
Dec 2019
92.50%
Average
95.00%
Median
Dec 2019
Max Drawdown (5Y) Benchmarks
AC Immune SA | 89.55% |
CRISPR Therapeutics AG | 81.61% |
Addex Therapeutics Ltd | -- |
NLS Pharmaceutics Ltd | -- |
Molecular Partners AG | -- |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | 15.23 |
Beta (5Y) | 0.0617 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 302.3% |
Historical Sharpe Ratio (5Y) | 0.053 |
Historical Sortino (5Y) | 0.3437 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 32.64% |